Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-020449
Filing Date
2021-06-09
Accepted
2021-06-09 19:29:15
Documents
1
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3689
  Complete submission text file 0001140361-21-020449.txt   5285
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address
Gallagher Cam (Reporting) CIK: 0001557832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 211006477